BackInnoviva Overview
Innoviva Inc

Innoviva Target Price

Where could INVA trade next? Consensus target price: $38.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.96

Average Target Price

$38.0081.3% upside

2 analysts in the last 4 months

High: $42 | Low: $34

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-07Cantor Fitzgerald$3462.2% upsideOpen
2026-05-07BTIG$42100.4% upsideOpen
2026-02-26Cantor FitzgeraldSteve Seedhouse$3252.7% upsideOpen
2026-02-17BTIG$3567% upsideOpen
2025-12-16H.C. Wainwright$46119.5% upsideOpen
2025-09-30Goldman Sachs$1718.9% downsideOpen
2025-08-11OppenheimerTrevor Allred$3567% upsideOpen
2025-03-07Scotiabank$55162.4% upsideOpen
2022-08-08Morgan Stanley$1338% downsideOpen
2022-07-15Morgan Stanley$1242.7% downsideOpen

Innoviva (INVA) FAQ

As of the most recent data, INVA shows a target price of $38. Scroll down for historical charts and peer comparison views.

If Innoviva moved to the average analyst target of $38, shares would be roughly 81.3% higher than $20.96. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Innoviva's earnings trajectory.

Besides this target price page, Stockcircle has Innoviva's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $38) with ownership activity and broader fundamentals.

Innoviva's target price is $38; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.